当大脑和心脏碰撞时:深入研究中风复杂化TAVI的治疗途径
Mark Kheifets1,2,3, Boris Kruchin4,5, Guy Witberg4,5
1Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel. mark.kheifets@outlook.com.
Cardiovascular intervention and therapeutics
|March 29, 2025
概括
急性缺血性中风并发症通过导管的大动脉植入 (TAVI) 增加死亡率. 神经干预 (NI) 并没有降低死亡率,但与保守管理 (CM) 相比,在中度中风患者中改善了无残疾生存率.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 干预心脏病学 干预心脏病学
背景情况:
- 周围手术性缺血性中风是跨导管大动脉植入 (TAVI) 的一个显著并发症.
- 了解急性缺血性中风并发症TAVI (AISCT) 的发生率,特征和结果对于患者管理至关重要.
研究的目的:
- 确定AISCT的发生率,特征和结果.
- 为了比较符合条件的AISCT患者的保守管理 (CM) 与神经干预 (NI).
主要方法:
- 从2008年至2021年连续的TAVI程序的回顾性分析.
- 用AISCT和没有AISCT的患者的比较.
- 在AISCT患者中NI和CM之间的结局的比较.
主要成果:
- AISCT的发生率为2.5% (38/1515名患者).
- AISCT与明显更高的30天,1年和3年全因死亡率有关.
- 与CM相比,NI没有降低死亡率,但在中度中风患者中改善了3个月的无残疾生存期.
结论:
- 在TAVI后,AISCT显著增加了死亡率.
- 神经干预可能会改善适合AISCT中风中症患者的功能结果,尽管它不会影响整体死亡率.
- 对AISCT最佳管理策略进行进一步的研究是有必要的.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...


